SYNERGISTIC TARGETING OF PI3K/AKT-PATHWAY AND ANDROGEN-RECEPTOR AXIS SIGNIFICANTLY DELAYS CASTRATION-RESISTANT PROSTATE CANCER PROGRESSION IN VIVO

被引：0
|
作者：
Thomas, Christian
Lamoureux, Francois
Crafter, Claire
Davies, Barry
Beraldi, Eliana
Fazli, Ladan
Kim, Soojin
Thaper, Daksh
Gleave, Martin
Zoubeidi, Amina
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词：
D O I：
10.1016/j.juro.2013.02.1703
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
318
引用
收藏
页码：E129 / E129
页数：1
相关论文
共 50 条
  • [1] Synergistic Targeting of PI3K/AKT Pathway and Androgen Receptor Axis Significantly Delays Castration-Resistant Prostate Cancer Progression In Vivo
    Thomas, Christian
    Lamoureux, Francois
    Crafter, Claire
    Davies, Barry R.
    Beraldi, Eliana
    Fazli, Ladan
    Kim, Soojin
    Thaper, Daksh
    Gleave, Martin E.
    Zoubeidi, Amina
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11) : 2342 - 2355
  • [2] Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer
    Bitting, Rhonda L.
    Armstrong, Andrew J.
    ENDOCRINE-RELATED CANCER, 2013, 20 (03) : R83 - R99
  • [3] Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis
    Scher, HI
    Sawyers, CL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (32) : 8253 - 8261
  • [4] Sophocarpine inhibits tumor progression by antagonizing the PI3K/AKT/mTOR signaling pathway in castration-resistant prostate cancer
    Weng, Min
    Shi, Chenghao
    Han, Hui
    Zhu, Hengyue
    Xiao, Yanyi
    Guo, Hangcheng
    Yu, Zhixian
    Wu, Cunzao
    PEERJ, 2022, 10
  • [5] Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC)
    Tsao, Che-Kai
    Galsky, Matthew D.
    Small, Alexander C.
    Yee, Tiffany
    Oh, William K.
    BJU INTERNATIONAL, 2012, 110 (11) : 1580 - 1588
  • [6] Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects
    R Ferraldeschi
    J Welti
    J Luo
    G Attard
    J S de Bono
    Oncogene, 2015, 34 : 1745 - 1757
  • [7] Co-targeting the PI3K and androgen receptor signal pathways in castration resistant prostate cancer
    De Velasco, Marco A.
    Kura, Yurie
    Ando, Naomi
    Fukushima, Emiko
    Hatanaka, Yuji
    Yamamoto, Yutaka
    Shimizu, Nobutaka
    Yoshimura, Kazuhiro
    Nozawa, Masahiro
    Yoshikawa, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    CANCER RESEARCH, 2014, 74 (19)
  • [8] Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects
    Ferraldeschi, R.
    Welti, J.
    Luo, J.
    Attard, G.
    de Bono, J. S.
    ONCOGENE, 2015, 34 (14) : 1745 - 1757
  • [9] Dual targeting of the PI3K/Akt/mTOR pathway significantly delays chondrosarcoma progression and relapse
    Jury, Delphine
    Decouvelaere, Anne Valerie
    Pasquier, Amandine
    Belvin, Marcia
    Friedman, Lode
    Langlois, Jean Baptiste
    Michol, Jean Philippe
    Blay, Jean Yves
    Dutour, Aurelie
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [10] The combination of carbidopa plus bicalutamide suppresses androgen-receptor transactivation, induces apoptosis and delays castration-resistant prostate cancer progression
    Thomas, C.
    Wafa, L. A.
    Lamoureux, F.
    Cheng, H.
    Fazli, L.
    Gleave, M. E.
    Rennie, P. S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E236 - E236
12345